Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction.

Arwen L Hunter1, Ni Bai, Ismail Laher

  • 1The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, Room 166 Burrard Building, St. Paul's Hospital, University of British Columbia, 1081 Burrard St., Vancouver, British Columbia, Canada, V6Z 1Y6.

Vascular Pharmacology
|September 10, 2005
PubMed
Summary

Sulfaphenazole, a cytochrome P450 inhibitor, protects against cardiac ischemia and reperfusion injury. It restores blood vessel function by reducing damaging superoxide production, highlighting CYP2C9

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise Intensity and Circulating Exerkine Responses: A Narrative Review of Selected Molecules.

Biomolecules·2026
Same author

Effects of Different Training Modalities on Circulating Irisin Levels in Overweight and Obesity Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Sports medicine (Auckland, N.Z.)·2026
Same author

The Effects of High-Thoracic Spinal Cord Injury on the Heart Transcriptome.

Journal of neurotrauma·2026
Same author

Short-term administration of L-citrulline augments cardiac vagal control and reduces blood pressure in response to high-intensity exercise in untreated hypertensive males.

European journal of applied physiology·2026
Same author

12‑weeks fisetin supplementation and interval resistance with aerobic training: changes in Maresin‑1 and inflammatory markers in men with obesity: a randomized controlled trial.

Journal of the International Society of Sports Nutrition·2026
Same author

Beetroot juice modulates physiological responses and accelerates recovery during the special judo performance: a randomized trial.

Scientific reports·2026

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Biochemistry

Background:

  • Cytochrome P450 (CYP) inhibitors offer protection against myocardial infarction from cardiac ischemia and reperfusion (I/R).
  • Post-ischemic endothelial dysfunction involves reduced nitric oxide (NO) bioavailability due to increased superoxide generation.
  • Sulfaphenazole inhibits CYP2C6 and CYP2C9, potentially impacting I/R injury outcomes.

Purpose of the Study:

  • To investigate if sulfaphenazole attenuates post-ischemic endothelial dysfunction.
  • To determine if sulfaphenazole reduces CYP-mediated superoxide generation following cardiac I/R.
  • To assess the role of CYP2C9 in post-ischemic vascular dysfunction.

Main Methods:

  • Rat hearts were perfused using the Langendorff mode, subjected to global ischemia and reperfusion (I/R).

Related Experiment Videos

  • Coronary resistance arteries were isolated to measure vasodilation responses to acetylcholine and endothelium-independent agents.
  • Superoxide production was assessed in heart tissues using dihydroethidium staining.

    • Main Results:

    • I/R reduced endothelium-dependent vasodilation, which was restored by sulfaphenazole pretreatment.
    • Sulfaphenazole did not restore vasodilation to endothelium-independent agents after I/R.
    • Sulfaphenazole significantly reduced I/R-induced superoxide production in arterial walls.

    Conclusions:

    • Sulfaphenazole restores post-ischemic, endothelium-dependent, NO-mediated vasodilation.
    • Reduced superoxide generation by sulfaphenazole is the likely mechanism for improved vascular function.
    • CYP2C9 appears to play a critical role in mediating post-ischemic vascular dysfunction.